The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease

Niamh Appleby; Toby A. Eyre; Maite Cabes; Aimee Jackson; Rebecca Boucher; Francesca Yates; Sonia Fox; Andrew Rawstron; Peter Hillmen; Anna Schuh

doi:10.1186/s12885-019-5717-y

The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease

Niamh Appleby, Toby A. Eyre, Maite Cabes, Aimee Jackson, Rebecca Boucher, Francesca Yates, Sonia Fox, Andrew Rawstron, Peter Hillmen, Anna Schuh

Cancer Research UK Clinical Trials Unit

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	BMC Cancer
DOIs	https://doi.org/10.1186/s12885-019-5717-y
Publication status	Published - Dec 2019

Access to Document

10.1186/s12885-019-5717-y

Cite this

Appleby, N., Eyre, T. A., Cabes, M., Jackson, A., Boucher, R., Yates, F., Fox, S., Rawstron, A., Hillmen, P., & Schuh, A. (2019). The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease. BMC Cancer. https://doi.org/10.1186/s12885-019-5717-y

@article{0eb4d24a0d4c4c7da21635cc5906128d,

title = "The STELLAR trial protocol: a prospective multicentre trial for Richter{\textquoteright}s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease",

author = "Niamh Appleby and Eyre, {Toby A.} and Maite Cabes and Aimee Jackson and Rebecca Boucher and Francesca Yates and Sonia Fox and Andrew Rawstron and Peter Hillmen and Anna Schuh",

year = "2019",

month = dec,

doi = "10.1186/s12885-019-5717-y",

language = "English",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "Springer",

}

Appleby, N, Eyre, TA, Cabes, M, Jackson, A , Boucher, R , Yates, F, Fox, S, Rawstron, A, Hillmen, P & Schuh, A 2019, 'The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease', BMC Cancer. https://doi.org/10.1186/s12885-019-5717-y

The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease. / Appleby, Niamh; Eyre, Toby A.; Cabes, Maite et al.
In: BMC Cancer, 12.2019.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease

AU - Appleby, Niamh

AU - Eyre, Toby A.

AU - Cabes, Maite

AU - Jackson, Aimee

AU - Boucher, Rebecca

AU - Yates, Francesca

AU - Fox, Sonia

AU - Rawstron, Andrew

AU - Hillmen, Peter

AU - Schuh, Anna

PY - 2019/12

Y1 - 2019/12

UR - http://dx.doi.org/10.1186/s12885-019-5717-y

U2 - 10.1186/s12885-019-5717-y

DO - 10.1186/s12885-019-5717-y

M3 - Article

SN - 1471-2407

JO - BMC Cancer

JF - BMC Cancer

ER -

Appleby N, Eyre TA, Cabes M, Jackson A , Boucher R , Yates F et al. The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease. BMC Cancer. 2019 Dec. doi: 10.1186/s12885-019-5717-y